… plasma and CSF biomarkers, and explore new proteomics-based strategies for identifying
additional CSF … Several promising novel blood biomarkers for AD have been documented. …

… Three core CSF biomarkers for the diagnosis of Alzheimer's … literature for 15 biomarkers in
both CSF and blood to assess … Plasma T-tau is the only blood biomarker that discriminates …

… that plasma NFL has a diagnostic performance comparable to the core AD CSF biomarkers,
… Future large longitudinal clinical studies are warranted to determine the potential for plasma …

… value of CSF and blood biomarkers closely … CSF biomarkers has emerged as an accurate
diagnostic and prognostic model. With respect to early diagnosis, the measurement of CSF …

… Herein, we review CSF and blood biomarkers for neuroinflammatory and neurodegenerative
diseases, with a focus on their potential applications in clinical trials. Specifically, we …

… and phosphorylated tau in cerebrospinal fluid (CSF). In blood, no single biomarker has been
… In this review, we summarize a range of the most promising CSF and blood biomarkers for …

… in blood, are largely lacking. We have investigated a broad set of protein biomarkers in
cerebrospinal fluid (CSF) and plasma … We identified and replicated 10 cerebrospinal fluid proteins …

… analysed CSF and plasma samples … CSF and plasma samples to identify potential biomarkers
for AD. Our study provides several notable findings. We observed that CSF NFL and CSF …

… biomarkers [cerebrospinal fluid (CSF) and blood]. As a complex and multifactorial disease,
AD biomarkers … In blood, no differences have been found in plasma α-synuclein between AD …

… Results look promising for plasma Aβ42/40 ratio as a blood biomarker for cerebral Aβ … In
AD, we have validated cerebrospinal fluid (CSF) biomarkers for Aβ plaque pathology (a reduced …